Clinical characteristics and risk factors of drug‐induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis

BACKGROUND: If anaplastic lymphoma kinase (ALK) gene rearrangement in lung cancer is identified, ALK‐tyrosine kinase inhibitors (ALK‐TKIs) can be an effective treatment. However, the details of drug‐induced lung injury (DILI) caused by ALK‐TKI, which can be a serious side effect of ALK‐TKIs, remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshikawa, Ken, Terada, Jiro, Abe, Mitsuhiro, Iwasawa, Shunichiro, Sakayori, Masashi, Yoshioka, Keiichiro, Hirasawa, Yasutaka, Kasai, Hajime, Kawasaki, Yohei, Tsushima, Kenji, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262910/
https://www.ncbi.nlm.nih.gov/pubmed/32237210
http://dx.doi.org/10.1111/1759-7714.13416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262910/
https://www.ncbi.nlm.nih.gov/pubmed/32237210
http://dx.doi.org/10.1111/1759-7714.13416

Ejemplares similares